| Chesapeake Eye Care & Laser Center | |
| 826 Washington Rd, Ste 200, Westminster, Maryland 21157 | |
| (410) 876-3333 |
| Name | Chesapeake Eye Care & Laser Center |
|---|---|
| Organization Name | Chesapeake Eye Care & Laser Center Llc |
| Location | 826 Washington Rd, Ste 200, Westminster, Maryland 21157 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 876-3333 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Dr. Thomas M. Rossi, President and Chief Executive Officer of Agile Therapeutics, Inc., will report on the company's progress in developing a new generation of transdermal contraceptives at the BIO 2007 annual international conference on biotechnology.
New research at the Guangdong Medical University suggests a laser-based approach could be the latest breakthrough in prostate cancer detection. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering (SERS) and a new mathematical analysis technique called support vector machine (SVM).
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.
The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, muscle relaxants, antiinflammatories, sedative hypnotics, pain relievers and nutriceuticals) have had limited success.
› Verified 9 days ago
| NPI Number | 1306042064 |
| Organization Name | CHESAPEAKE UROLOGY ASSOCIATES P.A. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 826 Washington Rd, Suite 215, Westminster, MD 21157 |
| Phone Number | 410-876-1633 |
News Archive
Dr. Thomas M. Rossi, President and Chief Executive Officer of Agile Therapeutics, Inc., will report on the company's progress in developing a new generation of transdermal contraceptives at the BIO 2007 annual international conference on biotechnology.
New research at the Guangdong Medical University suggests a laser-based approach could be the latest breakthrough in prostate cancer detection. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering (SERS) and a new mathematical analysis technique called support vector machine (SVM).
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.
The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, muscle relaxants, antiinflammatories, sedative hypnotics, pain relievers and nutriceuticals) have had limited success.
› Verified 9 days ago
| NPI Number | 1649467788 |
| Organization Name | CHESAPEAKE UROLOGY ASSOCIATES P.A. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 826 Washington Rd, Suite 215, Westminster, MD 21157 |
| Phone Number | 410-876-1633 |
News Archive
Dr. Thomas M. Rossi, President and Chief Executive Officer of Agile Therapeutics, Inc., will report on the company's progress in developing a new generation of transdermal contraceptives at the BIO 2007 annual international conference on biotechnology.
New research at the Guangdong Medical University suggests a laser-based approach could be the latest breakthrough in prostate cancer detection. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering (SERS) and a new mathematical analysis technique called support vector machine (SVM).
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.
The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, muscle relaxants, antiinflammatories, sedative hypnotics, pain relievers and nutriceuticals) have had limited success.
› Verified 9 days ago
News Archive
Dr. Thomas M. Rossi, President and Chief Executive Officer of Agile Therapeutics, Inc., will report on the company's progress in developing a new generation of transdermal contraceptives at the BIO 2007 annual international conference on biotechnology.
New research at the Guangdong Medical University suggests a laser-based approach could be the latest breakthrough in prostate cancer detection. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering (SERS) and a new mathematical analysis technique called support vector machine (SVM).
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.
The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, muscle relaxants, antiinflammatories, sedative hypnotics, pain relievers and nutriceuticals) have had limited success.
› Verified 9 days ago
Rite Aid Pharmacy 00347 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 250 Englar Rd, Westminster, Maryland 21157 Phone: (410) 876-1513 | |
Anchor Pharmacy &medical Supplies Type: Medicare Supplier Location: 205 Washington Heights Medical, Westminster, Maryland 21157 Phone: (410) 848-8900 | |
Cvs Pharmacy # 01330 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 Englar Road, Westminster, Maryland 21157 Phone: (410) 857-9000 | |
Cvs Pharmacy #16389 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 200 Malcolm Dr, Westminster, Maryland 21157 Phone: (410) 848-2152 | |
Wal-mart Pharmacy 10-1867 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 280 Woodward Rd, Westminster, Maryland 21157 Phone: (410) 857-9703 |